Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Crean

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Blood|October 24, 2002
Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survivalAnne Laurence Astier, Ronghui Xu, Marek Svoboda, et al.
Cardiovascular Diabetology|November 8, 2017
Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosisRobyn Bruen, Sean Curley, Sarina Kajani, et al.
Frontiers in Immunology|July 12, 2021
Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors <i>NR4A2</i> and <i>NR4A3</i> Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral ResponseDavid E Phelan, Masahiko Shigemura, Sarah Aldhafiri, et al.
Archives of Toxicology|April 10, 2014
Interleukin-19 as a translational indicator of renal injuryPaul Jennings, Daniel Crean, Lydia Aschauer, et al.
The American Journal of Pathology|August 13, 2013
Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activityJason P McMorrow, Daniel Crean, Martina Gogarty, et al.
ACS Applied Materials & Interfaces|March 14, 2024
Reproducible Synthesis of Biocompatible Albumin Nanoparticles Designed for Intra-articular Administration of Celecoxib to Treat OsteoarthritisRumi Khandelia, Tom Hodgkinson, Daniel Crean, et al.
Frontiers in Immunology|February 8, 2017
NR4A Receptors Differentially Regulate NF-κB Signaling in Myeloid CellsCaitriona McEvoy, Monica de Gaetano, Hugh E Giffney, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 24, 2014
Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testingDaniel Crean, Patricia Bellwon, Lydia Aschauer, et al.
Arthritis and Rheumatism|June 8, 2012
Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytesViviana Marzaioli, Jason P McMorrow, Hannes Angerer, et al.
Biochemical and Biophysical Research Communications|April 2, 2021
The NR4A agonist, Cytosporone B, attenuates pro-inflammatory mediators in human colorectal cancer tissue ex vivoMohamed Ismaiel, Brenda Murphy, Sarah Aldhafiri, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Blood|October 24, 2002
Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survivalAnne Laurence Astier, Ronghui Xu, Marek Svoboda, et al.
Cardiovascular Diabetology|November 8, 2017
Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosisRobyn Bruen, Sean Curley, Sarina Kajani, et al.
Frontiers in Immunology|July 12, 2021
Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors <i>NR4A2</i> and <i>NR4A3</i> Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral ResponseDavid E Phelan, Masahiko Shigemura, Sarah Aldhafiri, et al.
Archives of Toxicology|April 10, 2014
Interleukin-19 as a translational indicator of renal injuryPaul Jennings, Daniel Crean, Lydia Aschauer, et al.
The American Journal of Pathology|August 13, 2013
Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activityJason P McMorrow, Daniel Crean, Martina Gogarty, et al.
ACS Applied Materials & Interfaces|March 14, 2024
Reproducible Synthesis of Biocompatible Albumin Nanoparticles Designed for Intra-articular Administration of Celecoxib to Treat OsteoarthritisRumi Khandelia, Tom Hodgkinson, Daniel Crean, et al.
Frontiers in Immunology|February 8, 2017
NR4A Receptors Differentially Regulate NF-κB Signaling in Myeloid CellsCaitriona McEvoy, Monica de Gaetano, Hugh E Giffney, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 24, 2014
Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testingDaniel Crean, Patricia Bellwon, Lydia Aschauer, et al.
Arthritis and Rheumatism|June 8, 2012
Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytesViviana Marzaioli, Jason P McMorrow, Hannes Angerer, et al.
Biochemical and Biophysical Research Communications|April 2, 2021
The NR4A agonist, Cytosporone B, attenuates pro-inflammatory mediators in human colorectal cancer tissue ex vivoMohamed Ismaiel, Brenda Murphy, Sarah Aldhafiri, et al.
Pageof 4